These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 20182055

  • 1. No association between neuregulin 1 and psychotic symptoms in Alzheimer's disease patients.
    Middle F, Pritchard AL, Handoko H, Haque S, Holder R, Bentham P, Lendon CL.
    J Alzheimers Dis; 2010; 20(2):561-7. PubMed ID: 20182055
    [Abstract] [Full Text] [Related]

  • 2. Role of 5HT 2A and 5HT 2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease.
    Pritchard AL, Harris J, Pritchard CW, Coates J, Haque S, Holder R, Bentham P, Lendon CL.
    Neurobiol Aging; 2008 Mar; 29(3):341-7. PubMed ID: 17098333
    [Abstract] [Full Text] [Related]

  • 3. Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene.
    Craig D, Hart DJ, Carson R, McIlroy SP, Passmore AP.
    Neurosci Lett; 2004 Sep 16; 368(1):33-6. PubMed ID: 15342129
    [Abstract] [Full Text] [Related]

  • 4. Genetic variation in the G720/G30 gene locus (DAOA) influences the occurrence of psychotic symptoms in patients with Alzheimer's disease.
    Di Maria E, Bonvicini C, Bonomini C, Alberici A, Zanetti O, Gennarelli M.
    J Alzheimers Dis; 2009 Sep 16; 18(4):953-60. PubMed ID: 20009237
    [Abstract] [Full Text] [Related]

  • 5. Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease.
    Borroni B, Grassi M, Costanzi C, Zanetti M, Archetti S, Franzoni S, Caimi L, Padovani A.
    Neurobiol Aging; 2007 Aug 16; 28(8):1231-8. PubMed ID: 16837108
    [Abstract] [Full Text] [Related]

  • 6. Investigation of dopamine receptors in susceptibility to behavioural and psychological symptoms in Alzheimer's disease.
    Pritchard AL, Ratcliffe L, Sorour E, Haque S, Holder R, Bentham P, Lendon CL.
    Int J Geriatr Psychiatry; 2009 Sep 16; 24(9):1020-5. PubMed ID: 19235789
    [Abstract] [Full Text] [Related]

  • 7. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H.
    Int J Geriatr Psychiatry; 2007 May 16; 22(5):475-84. PubMed ID: 17471598
    [Abstract] [Full Text] [Related]

  • 8. Role of serotonin transporter polymorphisms in the behavioural and psychological symptoms in probable Alzheimer disease patients.
    Pritchard AL, Pritchard CW, Bentham P, Lendon CL.
    Dement Geriatr Cogn Disord; 2007 May 16; 24(3):201-6. PubMed ID: 17690552
    [Abstract] [Full Text] [Related]

  • 9. Investigation of the role of the dopamine transporter in susceptibility to behavioural and psychological symptoms of patients with probable Alzheimer's disease.
    Pritchard AL, Pritchard CW, Bentham P, Lendon CL.
    Dement Geriatr Cogn Disord; 2008 May 16; 26(3):257-60. PubMed ID: 18841010
    [Abstract] [Full Text] [Related]

  • 10. The interleukin 1beta gene promoter polymorphism (-511) acts as a risk factor for psychosis in Alzheimer's dementia.
    Craig D, Hart DJ, McCool K, McIlroy SP, Passmore AP.
    Ann Neurol; 2004 Jul 16; 56(1):121-4. PubMed ID: 15236409
    [Abstract] [Full Text] [Related]

  • 11. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
    Sweet RA, Devlin B, Pollock BG, Sukonick DL, Kastango KB, Bacanu SA, Chowdari KV, DeKosky ST, Ferrell RE.
    Mol Psychiatry; 2005 Nov 16; 10(11):1026-36. PubMed ID: 16027741
    [Abstract] [Full Text] [Related]

  • 12. PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
    Belbin O, Beaumont H, Warden D, Smith AD, Kalsheker N, Morgan K.
    Neurobiol Aging; 2009 Dec 16; 30(12):1992-9. PubMed ID: 18403054
    [Abstract] [Full Text] [Related]

  • 13. The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease.
    Devanand DP.
    Alzheimer Dis Assoc Disord; 1999 Nov 16; 13 Suppl 2():S3-8. PubMed ID: 10622673
    [Abstract] [Full Text] [Related]

  • 14. Delusion symptoms and response to antipsychotic treatment are associated with the 5-HT2A receptor polymorphism (102T/C) in Alzheimer's disease: a 3-year follow-up longitudinal study.
    Angelucci F, Bernardini S, Gravina P, Bellincampi L, Trequattrini A, Di Iulio F, Vanni D, Federici G, Caltagirone C, Bossù P, Spalletta G.
    J Alzheimers Dis; 2009 Nov 16; 17(1):203-11. PubMed ID: 19494443
    [Abstract] [Full Text] [Related]

  • 15. Neuregulin 1 gene and variations in perceptual aberration of schizotypal personality in adolescents.
    Lin HF, Liu YL, Liu CM, Hung SI, Hwu HG, Chen WJ.
    Psychol Med; 2005 Nov 16; 35(11):1589-98. PubMed ID: 16219117
    [Abstract] [Full Text] [Related]

  • 16. NRG1 and BDNF genes in schizophrenia: an association study in an Italian case-control sample.
    Squassina A, Piccardi P, Del Zompo M, Rossi A, Vita A, Pini S, Mucci A, Galderisi S.
    Psychiatry Res; 2010 Mar 30; 176(1):82-4. PubMed ID: 20061032
    [Abstract] [Full Text] [Related]

  • 17. Psychotic symptoms in frontotemporal dementia: prevalence and review.
    Mendez MF, Shapira JS, Woods RJ, Licht EA, Saul RE.
    Dement Geriatr Cogn Disord; 2008 Mar 30; 25(3):206-11. PubMed ID: 18204254
    [Abstract] [Full Text] [Related]

  • 18. Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association study.
    Laumet G, Chouraki V, Grenier-Boley B, Legry V, Heath S, Zelenika D, Fievet N, Hannequin D, Delepine M, Pasquier F, Hanon O, Brice A, Epelbaum J, Berr C, Dartigues JF, Tzourio C, Campion D, Lathrop M, Bertram L, Amouyel P, Lambert JC.
    J Alzheimers Dis; 2010 Mar 30; 20(4):1181-8. PubMed ID: 20413850
    [Abstract] [Full Text] [Related]

  • 19. DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study.
    Jönsson EG, Saetre P, Vares M, Andreou D, Larsson K, Timm S, Rasmussen HB, Djurovic S, Melle I, Andreassen OA, Agartz I, Werge T, Hall H, Terenius L.
    Neuropsychobiology; 2009 Mar 30; 59(3):142-50. PubMed ID: 19439994
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C, Solfrizzi V, Colacicco AM, D'Introno A, Frisardi V, Imbimbo BP, Lorusso M, Vendemiale G, Denitto M, Santamato A, Seripa D, Pilotto A, Fiore P, Capurso A, Panza F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):177-82. PubMed ID: 19897004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.